KET-RO
Official Title
Medication-assisted psychotherapy: Using ketamine-enhanced RODBT to target neural and behavioral mechanisms of action in emerging adults with moderate to severe depression
Study Details
The purpose of this study is to look at the effectiveness and possible success of combining a type of psychotherapy called Radically Open Dialectical Behavior Therapy (RO DBT) along with an FDA-approved medication called ketamine to possibly provide relief of symptoms of depression.
Principal Investigator
Kirsten Gilbert, PhD
IRB Number
202212113
Eligibility
Males and females ages 18-25
Moderate to severe persistent depression
No current or past psychosis
Compensation is provided for time and effort (contact the study team for compensation amount).
Volunteer Information
For more information about this study, contact Volunteer for Health at:
- 314.362.1000
- rprstaff@wustl.edu